177 related articles for article (PubMed ID: 27798717)
1. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.
Pu X; Storr SJ; Zhang Y; Rakha EA; Green AR; Ellis IO; Martin SG
Apoptosis; 2017 Mar; 22(3):357-368. PubMed ID: 27798717
[TBL] [Abstract][Full Text] [Related]
2. The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.
Campbell EJ; Tesson M; Doogan F; Mohammed ZMA; Mallon E; Edwards J
Br J Cancer; 2016 Oct; 115(8):967-973. PubMed ID: 27657341
[TBL] [Abstract][Full Text] [Related]
3. Calpain system protein expression in basal-like and triple-negative invasive breast cancer.
Storr SJ; Lee KW; Woolston CM; Safuan S; Green AR; Macmillan RD; Benhasouna A; Parr T; Ellis IO; Martin SG
Ann Oncol; 2012 Sep; 23(9):2289-2296. PubMed ID: 22745213
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
[TBL] [Abstract][Full Text] [Related]
5. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.
Habashy HO; Powe DG; Rakha EA; Ball G; Macmillan RD; Green AR; Ellis IO
Breast Cancer Res Treat; 2010 Apr; 120(3):603-12. PubMed ID: 19495959
[TBL] [Abstract][Full Text] [Related]
7. Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.
Davis J; Martin SG; Patel PM; Green AR; Rakha EA; Ellis IO; Storr SJ
BMC Cancer; 2014 Dec; 14():995. PubMed ID: 25539577
[TBL] [Abstract][Full Text] [Related]
8. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Storr SJ; Zhang S; Perren T; Lansdown M; Fatayer H; Sharma N; Gahlaut R; Shaaban A; Martin SG
Oncotarget; 2016 Jul; 7(30):47927-47937. PubMed ID: 27323818
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of breast cancer subtypes in patients with spinal metastases.
Wang M; Jensen AB; Morgen SS; Wu CS; Sun M; Li H; Dahl B; Bünger CE
Spine (Phila Pa 1976); 2014 Sep; 39(19):1620-7. PubMed ID: 24979144
[TBL] [Abstract][Full Text] [Related]
10. High nuclear MSK1 is associated with longer survival in breast cancer patients.
Pu X; Storr SJ; Ahmad NS; Rakha EA; Green AR; Ellis IO; Martin SG
J Cancer Res Clin Oncol; 2018 Mar; 144(3):509-517. PubMed ID: 29327245
[TBL] [Abstract][Full Text] [Related]
11. Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study.
Pu X; Storr SJ; Ahmad NS; Chan SY; Moseley PM; Televantou D; Cresti N; Boddy A; Ellis IO; Martin SG
Histopathology; 2016 Jun; 68(7):1021-9. PubMed ID: 26496999
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study.
Jin X; Jiang YZ; Chen S; Yu KD; Shao ZM; Di GH
Oncotarget; 2015 Apr; 6(11):9600-11. PubMed ID: 25826079
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
[TBL] [Abstract][Full Text] [Related]
14. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
17. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
Nassar A; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
20. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
